Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Food Scene
Community Directory
Community Service
Restaurant Guide
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Horizons
Outdoor Guide
Progress
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2022 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aileron Therapeutics Inc
(NQ:
ALRN
)
1.410
-0.030 (-2.08%)
Streaming Delayed Price
Updated: 2:19 PM EDT, Mar 22, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,547
Open
1.410
Bid (Size)
1.380 (1)
Ask (Size)
1.410 (8)
Prev. Close
1.440
Today's Range
1.370 - 1.440
52wk Range
1.250 - 15.00
Shares Outstanding
4,541,167
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Looking Into Aileron Therapeutics's Recent Short Interest
March 03, 2023
Aileron Therapeutics's (NASDAQ:ALRN) short percent of float has risen 50.0% since its last report. The company recently reported that it has 30 thousand shares sold short, which is 0.84% of all regular...
Via
Benzinga
S&P 500 Down 2%; Mobilicom Shares Spike Higher
February 21, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 2% on Tuesday. The Dow traded down 2.06% to 33,129.04 while the NASDAQ fell 2.39% to 11,506.10. The S&P...
Via
Benzinga
Performance
YTD
-55.94%
-55.94%
1 Month
-3.42%
-3.42%
3 Month
-41.98%
-41.98%
6 Month
-70.87%
-70.87%
1 Year
-83.72%
-83.72%
More News
Read More
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
Via
Benzinga
Aileron Therapeutics Shelves Development On Chemoprotection Agent, Shares Fall
February 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 21, 2023
Via
Benzinga
Dow Tumbles More Than 500 Points; US Manufacturing PMI Rises In February
February 21, 2023
Via
Benzinga
Nasdaq Drops Over 100 Points; Walmart Issues Cautious Forecast
February 21, 2023
Via
Benzinga
Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
February 21, 2023
From
Aileron Therapeutics, Inc.
Via
Globe NewsWire
Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements
November 30, 2022
From
Aileron Therapeutics, Inc.
Via
Globe NewsWire
Aileron Therapeutics Announces a 1-for-20 Reverse Stock Split
November 10, 2022
From
Aileron Therapeutics, Inc.
Via
Globe NewsWire
Aileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
November 01, 2022
From
Aileron Therapeutics, Inc.
Via
Globe NewsWire
Aileron Therapeutics Presents Results from Phase 1 Study in Healthy Volunteers Demonstrating ALRN-6924 Induced Cell Cycle Arrest in Bone Marrow Stem Cells and Hair Follicles at EORTC-NCI-AACR International Conference
October 26, 2022
From
Aileron Therapeutics, Inc.
Via
Globe NewsWire
Aileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at the European Society for Dermatological Research Annual Meeting 2022
September 30, 2022
From
Aileron Therapeutics, Inc.
Via
Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 20, 2022
Via
Benzinga
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
September 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 25, 2022
Via
Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
August 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 08, 2022
Via
Benzinga
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
August 08, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 05, 2022
Via
Benzinga
Why Is Marker Therapeutics Trading Higher By 119%: Here Are 42 Stocks Moving Premarket
August 05, 2022
Via
Benzinga
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
August 03, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 02, 2022
Via
Benzinga
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
August 02, 2022
Via
Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
August 02, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
